Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,236.07
-38.03
(-0.10%)
HANG SENG
18,427.16
-48.76
(-0.26%)
CRUDE OIL
78.41
+0.30
(+0.38%)
GOLD FUTURES
2,320.80
+12.20
(+0.53%)
DOW
38,675.68
+449.98
(+1.18%)
Bitcoin GBP
51,028.41
+542.15
(+1.07%)
BRANDS
Meet one of the UK’s largest unknown start-ups
Video editing platform Veed has grown to 10 million users
Innate Pharma S.A. (0EVI.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
2.2050
+0.0125
(+0.57%)
At close: 04:04PM BST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
51,901
51,901
49,580
12,110
56,155
Cost of revenue
-
-
-
-
3,042
Gross profit
-
-
-
-
53,791
Operating expenses
Research development
56,022
56,022
51,663
47,004
49,708
Selling general and administrative
11,748
11,748
14,473
15,991
12,691
Total operating expenses
64,570
64,570
66,005
59,937
55,076
Operating income or loss
-12,669
-12,669
-16,425
-47,827
1,079
Interest expense
640
640
288
312
341
Total other income/expenses net
2,562
2,562
-41,805
2,330
-2,131
Income before tax
-7,570
-7,570
-57,972
-45,478
-829
Income tax expense
0
0
0
0
0
Income from continuing operations
-7,570
-7,570
-57,972
-45,478
-829
Net income
-7,570
-7,570
-58,103
-52,809
-63,984
Net income available to common shareholders
-7,570
-7,570
-58,103
-52,809
-63,984
Basic EPS
-0.79
-
-0.73
-0.66
-0.81
Diluted EPS
-0.79
-
-0.73
-0.66
-0.81
Basic average shares
79,923
-
79,640
79,543
78,935
Diluted average shares
79,923
-
79,640
79,543
78,935
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.